Kadcyla has been found to extend the lives of patients by up to nine months longer than those taking an alternative drug An urgent petition has been launched by a charity against a controversial draft decision which could block a pioneering breast cancer treatment from being routinely available on the NHS. Breast Cancer Now has condemned a preliminary recommendation from the National Institute for Health and Care Excellence to reject Kadcyla as a “disastrous decision” which is “a huge setback” for the treatment of advanced breast cancer.